Cargando…
Expanding transcatheter aortic valve replacement into uncharted indications
Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its s...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943666/ https://www.ncbi.nlm.nih.gov/pubmed/29551053 http://dx.doi.org/10.3904/kjim.2018.015 |
_version_ | 1783321674330931200 |
---|---|
author | Kang, Guson Kim, Juyong Brian |
author_facet | Kang, Guson Kim, Juyong Brian |
author_sort | Kang, Guson |
collection | PubMed |
description | Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its safety and efficacy have expanded its use in intermediate and possibly low surgical risk patients. In this review, we explore the past, present, and future of transcatheter aortic valve replacement. |
format | Online Article Text |
id | pubmed-5943666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-59436662018-05-16 Expanding transcatheter aortic valve replacement into uncharted indications Kang, Guson Kim, Juyong Brian Korean J Intern Med Review Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its safety and efficacy have expanded its use in intermediate and possibly low surgical risk patients. In this review, we explore the past, present, and future of transcatheter aortic valve replacement. The Korean Association of Internal Medicine 2018-05 2018-03-20 /pmc/articles/PMC5943666/ /pubmed/29551053 http://dx.doi.org/10.3904/kjim.2018.015 Text en Copyright © 2018 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Kang, Guson Kim, Juyong Brian Expanding transcatheter aortic valve replacement into uncharted indications |
title | Expanding transcatheter aortic valve replacement into uncharted indications |
title_full | Expanding transcatheter aortic valve replacement into uncharted indications |
title_fullStr | Expanding transcatheter aortic valve replacement into uncharted indications |
title_full_unstemmed | Expanding transcatheter aortic valve replacement into uncharted indications |
title_short | Expanding transcatheter aortic valve replacement into uncharted indications |
title_sort | expanding transcatheter aortic valve replacement into uncharted indications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943666/ https://www.ncbi.nlm.nih.gov/pubmed/29551053 http://dx.doi.org/10.3904/kjim.2018.015 |
work_keys_str_mv | AT kangguson expandingtranscatheteraorticvalvereplacementintounchartedindications AT kimjuyongbrian expandingtranscatheteraorticvalvereplacementintounchartedindications |